Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies againstHelicobacter pyloriinfection
- 1 January 2006
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (1), 232-236
- https://doi.org/10.1111/j.1440-1746.2006.04171.x
Abstract
A proton pump inhibitor (PPI)-based triple therapy with clarithromycin (CAM) and amoxicillin (AMPC) is now a standard regimen for Helicobacter pylori (HP) eradication in Japan. However, the CAM-resistant rate has increased recently and alternative therapies are sorely needed. Therefore the aim of the present study was to evaluate the effectiveness and safety of the PPI-tetracycline (TC)-metronidazole (MNZ) regimen (the PTM regimen) as an alternative therapy in comparison with the PPI-AMPC-MNZ (PAM) regimen. Sixty-four HP-positive patients visiting the HP-eradication clinic in Tokai University Hospital from July 1998 to March 2003 were treated with either PTM or PAM as alternative therapies. The HP eradication was assessed by urea breath test (UBT), HP stool antigen test, or HP culture method more than 2 months after completion of the treatments. The drug resistances against CAM, AMPC, TC, and MNZ were assessed by the agar dilution method. Fifty-six patients (26 PTM and 30 PAM) completed medication and evaluation of the eradication. The eradication rates of PTM were 82.8% (24/29) and 92.3% (24/26), while those of PAM were 74.3% (26/35) and 89.7% (26/29) by intention-to-treat and per-protocol analysis, respectively. The differences between the regimens were not statistically significant. There were no severe adverse effects observed in either of the regimens. The drug-resistance analyses showed 15 CAM- and one MNZ-resistant cases but no TC or AMPC resistance in the available 25 samples. The PTM and PAM regimens were equally effective and safe as alternative HP eradication therapies. And PTM would be particularly useful in penicillin allergy cases.Keywords
This publication has 22 references indexed in Scilit:
- High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2004
- Helicobacter pylori and gastric malignanciesHelicobacter, 2003
- Helicobacter pylori and extragastric diseases - Other HelicobactersHelicobacter, 2003
- Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategiesAlimentary Pharmacology & Therapeutics, 2003
- Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patientsThe Esophagus, 2003
- A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE studyGastroenterology, 2002
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Clarithromycin resistance in Helicobacter pylori: implications for therapyThe Esophagus, 2000
- Helicobacter pyloriCurrent Opinion in Gastroenterology, 1997